|
|
||||||||
a UBC Center for Proteomics, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada;
b Center for Experimental BioInformatics,
c Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark;
d Department of Endocrinology, University Hospital of Odense, Odense C, Denmark
Key Words. Proteome • Osteoblast • Differentiation • Stem cells • Mesenchymal stem cells • Membrane proteins
Correspondence: Moustapha Kassem, M.D., Ph.D., D.Sci., Department of Endocrinology and Metabolism, University Hospital of Odense, DK-5000 Odense C, Denmark. Telephone: 45-6541-1606; Fax: 45-6591-9653; e-mail: moustapha.kassem{at}ouh.fyns-amt.dk
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Few studies have tried to identify new molecular markers of hMSCs because most investigations have used hybridoma technology to obtain monoclonal antibodies against subsets of MSCs [4, 5, 9]. Although informative, this method is too focused to provide a global understanding of changes in the membrane phenotype of MSCs during differentiation. Mass spectrometry (MS)based proteomics tools can be applied qualitatively to gain a more holistic view of biological systems, as seen in recent studies of keratinocytes [10] and the osteoclast secretome [11]. However, quantitative proteomics methods allow dynamic changes in cell differentiation stages to be followed on the same broad scale, potentially revealing much more insight into the system of interest. Of particular relevance to this study, Conrads et al. [12] have used isotope-coded affinity tags to examine the effects of inorganic phosphate on the murine OB proteome. The choice of MS instrument and database search parameters can also have a large impact on the reliability of protein identifications [13], leading to unacceptably high levels of false-positive identifications if criteria are not stringent enough.
Application of proteomics to human stem cell biology has been hampered by the lack of physiologically relevant cell models that can be expanded to generate the levels of material required for such studies. We have recently developed a cell model for hMSCs by overexpressing the human telomerase reverse transcription (hTERT) gene in normal hMSCs and thus created a cell line termed hMSC-TERT that maintains the phenotypic characteristics and hormonal responsiveness of normal hMSCs despite extensive cell proliferation [14, 15]. To gain some understanding of the process of OB differentiation of hMSCs, we have enriched membrane proteins from hMSC-TERT before and after induction of OB lineage commitment in short-term culture in vitro. Using quantitative, MS-based proteomics, we have identified 463 proteins with very high confidence and have measured their changes in expression induced by OB differentiation. Several marker proteins of stem cells and OB were identified, along with several new candidate proteins with putative roles in stem cell proliferation and differentiation. For those gene products changing most dramatically, we have also measured the concomitant changes in their mRNA expression levels by reverse transcription (RT) real-time polymerase chain reaction (PCR) and confirmed the protein level changes for three of them by cytochemistry and confocal immunofluorescence microscopy.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1 (1:100, a kind gift from Dr. Juha Risteli [16]), Alexa488-conjugated chicken anti-mouse (1:250; Molecular Probes Inc., Eugene, OR, http://probes.invitrogen.com), and Cy3-conjugated donkey anti-rabbit (1:250; Jackson Immunoresearch Laboratories, West Grove, PA, http://www.jacksonimmuno.com).
Cell Culture
hMSC-TERT [14] cells were maintained in 145-cm2 Petri dishes in minimal essential medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. For induction of OB differentiation [8, 15], cells were seeded at 3.0 x 105 cells per 9.6-cm2 Petri dish and left to attach overnight. The media was then changed to either control media (as above with added vehicle) or OB differentiation media (control media supplemented with calcitriol [10 nM]), and 48 hours later, the media was replenished. The cells were harvested on day 4 by washing them twice with phosphate-buffered saline (PBS), allowing them to detach in CDB according to the manufacturers instructions, and then pelleting them at 1000g.
Subcellular Fractionation
The cell pellet from two 145-cm2 dishes was washed twice in PBS, resuspended in a hypotonic buffer (20 mM KCl, 10 mM HEPES, pH 7.4) for 2 minutes, and collected again by centrifugation (1000g, 5 minutes). The resulting pellet was resuspended in sucrose homogenization buffer (255 mM sucrose, 20 mM HEPES, 1 mM EDTA, pH 7.4, 4°C) containing complete protease inhibitor tablets and transferred to a 7-ml glass homogenizer (Wheaton Science Products, Hojbjerg, Denmark, http://www.wheatonsci.com), where the cells were broken with five strokes with the loose pestle and 35 strokes with the tight pestle [17]. The number of strokes was determined empirically during preliminary experiments under the described conditions by observing via phase-contrast microscopy when more than 95% of the cells were broken. The cell lysates were transferred to microfuge tubes and centrifuged at 14,000g for 10 minutes, after which the resulting supernatant was transferred to 4-ml polycarbonate tubes and centrifuged at 245,000g for 2 hours at 4°C. The pellet from this step was resuspended in 100 mM Na2CO3 (pH 11) and disrupted mechanically using a 25-gauge syringe before incubating with rotation for 90 minutes at 4°C. Finally, the membranes were collected by centrifugation for a further 90 minutes at 245,000g. Each preparation from two 145-cm2 dishes of cells yielded approximately 50 µg of protein. All fractionation steps were carried out at 4°C or on ice.
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
The membrane pellet was solubilized in deionized 6-M urea/2-M thiourea buffered by 20 mM Tris (pH 8.0), reduced, alkylated, and digested to peptides with trypsin and endopeptidase LysC as described [18]. Ten micrograms of total peptide mass from each sample was desalted/concentrated/filtered as described [19] and transferred to 96-well sampling plate.
Peptides were eluted from the analytical column by three-step, 140-minute gradient running from 2%80% Buffer B and sprayed directly into the orifice of a QSTAR-Pulsar quadrupole time-of-flight (TOF) hybrid mass spectrometer (PE-Sciex, Thornhill, Ontario, Canada, http://www.sciex.com) or an LTQ-FT linear ion trap-Fourier transform mass spectrometer (Finnigan, Bremen, Germany, http://www.thermo.com) [20]. Both mass spectrometers were set up in a data-dependent acquisition mode in which multiply charged peptides were selected for fragmentation. In the QSTAR, fragmentation was accomplished by collision-induced dissociation and the fragments were measured in the TOF region, whereas in the LTQ-FT, fragmentation was carried out in the ion-trap and resulting fragments were measured using the ion-trap detectors. The QSTAR acquired four fragment spectra for every survey scan, giving a cycle time of approximately 5 seconds. The LTQ-FT was set to acquire five-fragment spectra in the ion trap, while at the same time the FT detector was measuring a full m/z range survey scan at 100,000 resolution, resulting in a cycle time of approximately 1.5 seconds.
Protein Identification
Fragment spectra were searched against the Human International Protein Index (IPI) database (March 1, 2004) (ftp://ftp.ebi.ac.uk/pub/databases/IPI/current/) by using Mascot Server (Matrix Science, London, http://www.matrixscience.com). The following search parameters were used in all Mascot searches: tryptic cleavage rules with a maximum of one missed cleavage, cysteine carbamidomethylation, methionine oxidation, fragmentation rules appropriate for the instrument (ESI-QUAD-TOF for QSTAR, ESI-TRAP for LTQ-FT), and mass accuracies appropriate for the instrument (a maximum 0.2-Da error tolerance for the QSTAR in both the MS and MS/MS data and a maximum 9 ppm for MS and 0.5-Da error tolerance for MS/MS for the LTQ-FT). Peptides identified using these criteria were then filtered further after iterative mass recalibration. For QSTAR data, peptides with an IonsScore >40 were accepted without further verification whereas those with IonsScores between 30 and 40 were manually verified by criteria consistent with Q-TOFtype fragmentation (a minimum length of eight amino acids, a consecutive y-ion series of at least three ions, or the presence of an intense terminal proline ion). For LTQ-FT data, peptides were accepted only if they had an IonsScore greater than 25, containing more than seven amino acids, and had a relative mass error of less than 9 ppm. In total, 4,200 unique peptides that met these conditions were identified, so the fragment spectra were also searched against the reversed human IPI database [21] to establish statistical rates of false-positive identifications. In this way, 46 peptides with similar criteria were identified, resulting in a false-positive rate of 46/4,200, or 1.1%, on the peptide level. Therefore, proteins were considered identified only if they were observed in at least two of the three pairs of samples analyzed and if two or more unique peptides meeting the above criteria were sequenced, giving a potential false-positive rate of approximately 1 in 10,000.
To completely eliminate redundant protein identifications in the final protein list reported here, the peptides were researched against the most recent human IPI database (v2.37) using the PAM30 scoring matrix for BLAST (Basic Local Alignment Search Tool) searches with short sequences (ftp://ftp.ncbi.nih.gov/blast/executables/) and the results were compiled into protein hits. Finally, any protein hit whose set of identifying peptides was equal, to or a subset of, another hit was considered redundant and removed. In this way, distinct protein isoforms were retained only if they were distinguished from others by at least one unique peptide. Manual verification of spectral assignments from Mascot result files, iterative mass recalibration, elution time correlation, and extraction of quantitative data from the raw data files was performed using MSQaunt (http://msquant.sourceforge.net) [22]. When a peptide was not identified by tandem MS, its elution time was predicted from the correlation of the control and differentiated samples to extract the correct ion current [23]. Due to limitations in the linear dynamic range of QSTARs when measuring differences greater than 10-fold, we report ratios greater than this limit as > (i.e., >27) with no SD [18]. The average R2 value for the correlation of elution times between two consecutive LC/MS/MS experiments was greater than 0.99, indicating the reliability of elution time prediction. Peptide ion volumes (time x ion count x mass window [Da·s]) were calculated by integration of the XIC (eXtracted Ion Chromatogram), from which the ratios of OBs differentiated to hMSCs were calculated. Assignments of all extracted ion chromatograms were manually verified. All protein and corresponding peptide data were stored in an SQL 2000 (Microsoft, Redmond, WA, http://www.microsoft.com) relational database. Gene Ontology (GO) annotations (ftp://ftp.geneontology.org/pub/go/gene-associations/) were assigned to each identified protein by an automated, in-house script using the human cross-reference table (ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/HUMAN/xrefs.goa). Transmembrane domains were predicted using the TMpred algorithm (http://www.ch.embnet.org/software/TMPRED_form.html). Sequence coverage (supplemental online Fig. 1) was mapped using the coverage tool from Proteios (http://www.proteios.org/proj/coverage).
RT and Real-Time PCR
Total RNA was isolated by RNAElute kit (Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) according to the manufacturers instructions, after which the RNA samples were treated with DNase I (Roche Molecular Biochemicals, Basel Switzerland, http://www.roche-applied-science.com). The cDNA was prepared from 2 µg of total RNA with cDNA synthesis Kit (Bio-Rad, Hercules, CA, http://www.bio-rad.com) in a final volume of 20 µl. The primers for all assayed genes were designed using the PrimerSelect program of the Lasergene software package (DNA-STAR, Madison, WI, http://www.dnastar.com/web/index.php). For a single PCR amounting to 20 µl, 0.1 µl of cDNA was used. SYBR Green I supermix (Bio-Rad) was used to visualize PCR products in real time. A three-temperature cycling, consisting of a denaturation step at 95°C for 15 seconds and annealing/extension step at 50°C to 68°C for 20 seconds, 72°C for 20 seconds, was carried out in an iCycler instrument (Bio-Rad). Optimal annealing temperatures were determined for each gene, the lengths of the PCR products were verified by agarose gel electrophoresis, and melting curve analysis was used to assess the specificity after each PCR. ß-Actin was used as an endogenous standard to normalize for input load of cDNA between the samples. For the quantitative analysis of the individual genes, two independent cDNA samples were prepared and each of the cDNAs was tested in duplicate.
Staining for Alkaline Phosphatase Activity
Cells were washed in PBS twice and fixed in methanol/formalin (9:1) for 1 minute. The cells were incubated with alkaline phosphatase (ALP) substrate solution (5 mg naphthol AS-TR phosphate in 25 ml water plus 10 mg Fast red TR in 24 ml of 0.1 M Tris buffer, pH 9.5) for 1 hour at room temperature. Mayers-hematoxylin was used as a counter-stain. Cells were photographed using an Olympus IX 50 inverted microscope (Olympus, Albertslund, Denmark, http://www.olympus.com) equipped with an Olympus C3040 zoom digital camera (magnification x40).
Immunocytochemical Staining
Control and OB-differentiated cells were grown on coverslips and fixed in 4% formaldehyde in PBS (all PBS solutions contained 1.04 mM MgCl2 and 0.9 mM CaCl2) for 10 minutes on ice. Excess formaldehyde was reacted with 50 mM NH4Cl in PBS for 5 minutes, and then nonspecific immunoglobulin-G binding sites were blocked for 20 minutes with 3% bovine serum albumin in PBS. Primary and secondary antibody incubations were each 1 hour, and coverslips were washed four times with PBS after each. Coverslips were mounted on glass slides using Dako Fluorescent Mounting Solution (DakoCytomation, Glostrup, Denmark, http://www.dakocytomation.com) and imaged using an Axiovert 200M laser-scanning confocal microscope 510 (Carl Zeiss, Jena, Germany, http://www.zeiss.com). Pinhole settings were adjusted to give a confocal depth of approximately 1 µm.
| RESULTS |
|---|
|
|
|---|
|
Classification of the subcellular localizations of 463 proteins based on annotations in the UniProt Knowledgebase(http://www.ebi.uniprot.org/index.shtml) and the Gene Ontology Consortium revealed several classes of enriched proteins (Fig. 2A
). Sixty-six percent are integral membrane proteins, proteins with known or predicted membrane anchors or proteins known to interact with other membrane proteins. These included all known markers of MSCs, including ALP, 5'-nucleotidase (CD73), Thy-1 glycoprotein (CD90), neprilysin (CD10), myeloid plasma membrane glycoprotein (CD13), endoglin (CD105), activated leukocyte-cell adhesion molecule (CD166), HOP26 (CD63), integrin ß1 (CD29), integrin
5 (CD49e), integrin
4 (CD49d), phagocytic glycoprotein I (CD44), fibronectin, collagen type VI, and epidermal growth factor receptor [3, 2426]. Other CD antigens detected were CD98, CD59, CD51, CD107b, CD107a, CD 91, CD99, CD71, CD47, and CD108. Also, several members of the integrins, integrin alpha 11, integrin beta-5, integrin alpha-2 (CD49b), integrin alpha-6 (CD49f), integrin alpha-V (CD51), and integrin alpha-3 (CD49c), were detected (see supplemental material).
|
-helical transmembrane domain (TMD) predicted in their primary sequence, 11 more than were classified as integral membrane based on their UniProt annotations. Most proteins contained either one or two TMDs, but many proteins with several TMDs were also detected (Fig. 2B
Induction of OB differentiation of hMSC-TERT cells in our experiments was confirmed by the presence of increased expression of four OB-specific genes: ALP, collagen type I (COL1), osteopontin and osteocalcin, and bone sialoprotein 2 (BSP2) (Fig. 3A
). Our working hypothesis in this study was that markers of OB differentiation should show an OB/hMSC ratio greater than or less than 1. As expected, ALP, detected here with 9% sequence coverage, displayed the highest OB/hMSC ratio (>27, Fig. 1C
and supplemental online material) of all the proteins quantified in this study. The expression levels of several other proteins also increased or decreased with OB differentiation. To determine a significance threshold for these changes, we first considered the measurement errors in this analysis. The average relative SD of OB/hMSC ratios measured here was 47%, so we considered any protein whose expression level changed by at least this, or twofold in either direction, to be of potential interest. Based on these criteria, we identified 83 proteins that increased at least twofold and 21 proteins that decreased at least twofold (Table 1
and supplemental online material).
|
|
Although the quantitative analysis of hMSC and OB membranes revealed several proteins whose expression levels changed dramatically, our dataset also contains a great deal of additional information. We asked if there are any functional classes of proteins identified in this study that are coregulated during OB differentiation. Mapping GO terms (see Materials and Methods) to the proteins identified here revealed several functional classes of proteins displaying very close coregulation (Table 2
). In particular, all nine proteins annotated in the cell-matrix adhesion and integrin receptor signaling pathway GO categories displayed remarkably consistent changes in their expression levels, increasing an average of 2.0 ± 0.5fold with OB differentiation. All five heteronuclear ribonuclear proteins (hnRNPs) increased even more dramatically with OB differentiation (6.9 ± 4.0fold).
|
| DISCUSSION |
|---|
|
|
|---|
To obtain the large number of cells needed to conduct an in-depth, proteomic characterization, we used the hMSC-TERT cell line that expresses a high level of telomerase due to ectopic expression of hTERT gene as a model for normal hMSCs [14, 15]. The cells express CD105 and CD166, as well as Stro-1, the markers currently used to identify multipotential hMSCs [3, 26]. In addition, the data presented here show that hMSC-TERT expresses other surface markers known to reside in normal hMSCs [3, 2426], indicating that the telomerase overexpression did not affect the phenotypic make up of the cells.
Several proteins were identified in this analysis that have not been described previously in MSCs and may play an important role in hMSC biology. Among these were several integrins (e.g., Cd49f, CD49c, integrin
11, integrin
2, and integrin-linked protein kinase) and CD antigens (e.g., CD98, CD147, and CD99). Previous reports concerning the functions of these proteins may suggest an important role for them in hMSC biology. For example, CD98 is known for its possible role for cell growth and amino acid transport in placenta [27], CD147 is an extracellular metalloproteinase inducer expressed largely in endothelial cells, CD99 is involved in cell adhesion, and CD47 (integrin-associated protein) plays a role in increased intracellular calcium upon cell adhesion to extracellular matrix. Thus, more detailed studies are needed to determine the role of these proteins in hMSC biology.
Traditionally, few protein markers are used to monitor OB differentiation based on studies performed on cultured OB from rat calvaria in vitro [6, 7]. Only ALP, as a glycosylphosphatidylinositol-anchored protein, is expected to be associated with membranes. In addition to the upregulation of ALP observed here, several candidate marker proteins for OB differentiation have also been identified, and one, versican core protein, has been confirmed by immunocytochemistry. Versican, or chondroitin sulphate proteoglycan, is known to be secreted later in the bone development process but was not previously considered a marker of early OB differentiation. We also identified two of the proteins that versican is known to interact with in the extracellular matrix, CD44 and tenascin. Tenascin likely functions to stop cell migration [28], so it is interesting to note that its expression was also significantly increased upon OB differentiation (4.1 ± 0.1). The observed coregulation of these two known binding partners, versican and tenascin, may suggest that these proteins work together to stop cell migration and allow OB differentiation to proceed, but this hypothesis needs experimental confirmation.
The concomitant upregulation of entire functional classes of proteins during differentiation suggests that these proteins are intimately involved in the differentiation process and that their regulation proceeds through similar regulatory mechanisms. Our observation that integrins and adhesion molecules increase during OB differentiation (Table 2
) corroborates previous observations [29] and extends the family of proteins known to exhibit this role. In light of a recent report linking hnRNPs to cell adhesion [30], our finding that five members of this family are upregulated as cells differentiate into OB lends additional support to the critical role of adhesion in the differentiation process.
While most proteins that changed during OB differentiation were found to increase, several proteins were also observed to be downregulated. Most strikingly, FAS decreased upon OB differentiation. FAS is a homodimeric, multifunctional protein that catalyzes the synthesis of long-chain fatty acids and is expressed during adipocyte differentiation [31] as well as in proliferating cells of the bone marrow [32]. Its downregulation during OB differentiation likely reflects the decreased lipid metabolism and the nonproliferative nature of cells committed to the OB lineage.
Because this study was conducted in cultured cells, a stable isotope labeling (SIL) method such as SILAC (SIL with Amino acids in Cell culture)[29, 30] would be a viable alternative to the ion intensity-based quantitation we have used here. However, our method has the advantage that it can be extended to the proteomic analysis of human biopsies, in which the cells cannot be effectively labeled using metabolic means and the amount of available sample is extremely limiting. Chemical SIL methods generally require several hundred micrograms or milligrams of starting material, as do extensive cell fractionation methods to further enrich plasma membranes [10, 33, 34]. For these reasons, we have avoided extensive subcellular fractionation and SIL methods here to develop effective procedures for analyzing limited normal human material.
The advent of large-scale methods for detecting both protein and mRNA abundance has revealed a surprising lack of correlation between the message and the product [35, 36] for as-yet-unknown reasons. A similar situation was observed here, although there are at least two potential reasons explaining the lack of concordance between changes in protein and mRNA levels during differentiation: Changes in mRNA levels may have peaked and returned to normal levels before our measuring them, and gene expression data reflect changes on the level of the whole cell while membrane proteomics does not necessarily represent the entire complement of a protein within a cell. Our procedure should represent all integral membrane proteins and those anchored to membranes by a lipid tail because we analyzed all postnuclear, postmitochondrial membranes. However, for proteins associating with membranes via protein-protein interactions, or, in other terms, those whose association is easily reversed, the changes measured here may represent changes in the levels of association with the membrane rather than changes in protein expression levels.
Our study has some limitations. First, we used the hMSC-TERT as a model for normal hMSCs. Although the hMSC-TERT cells exhibit surface marker expression and differentiation potential similar to that of normal hMSCs, hTERT overexpression may affect other biological functions of the cells, and thus the new surface markers identified in our study need to be confirmed in cultures of normal hMSCs. Second, we used short-term treatment with calcitriol in the presence of fetal calf serum to induce the OB phenotype. This method succeeded in inducing several known mRNA OB-specific gene markers, indicating commitment to OB lineage. However, histochemical staining for ALP revealed cellular heterogeneity with respect to the degree and intensity of staining, suggesting that not all the cells were synchronized with respect to OB differentiation. Experiments using a stronger osteogenic-differentiation mixture that contains ß-glycerophosphate, ascorbic acid, and dexamethasone may have resulted in a better OB-phenotype induction. Because this differentiation mixture can also induce mineralization in vitro, it can be used to obtain mature matrix-mineralizing osteoblastic cells for analysis. Also, alternative methods for obtaining homogenous populations of differentiated cells using hMSC lines expressing reporter genes at specific OB differentiation stages may have overcome the issue of cellular heterogeneity observed in our cultures. This approach has been applied to smooth muscle cell differentiation [37] and hMSCs [38]. Finally, several of the detected proteins are not specific for hMSCs and are present in other cell types. It remains to be determined whether combining several of these new markers will increase the sensitivity for identification and isolation of hMSCs and their differentiated progeny.
In conclusion, we have reported a very high confidence profile of the membrane proteome of hMSCs during OB differentiation. We have identified several new potential molecular markers of hMSCs at both the undifferentiated and OB differentiated stage that can be potentially useful in understanding the biology of hMSCs. The increased expression levels of 16 proteins known or implicated in cell adhesion (nine cell matrix adhesion proteins, five hnRNPs, versican, and tenascin) suggests the importance of OB adhesion to the underlying matrix in the process of OB differentiation.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
DISCLOSURES
The authors indicate no potential conflicts of interest.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Kasper, L. Mao, S. Geissler, A. Draycheva, J. Trippens, J. Kuhnisch, M. Tschirschmann, K. Kaspar, C. Perka, G. N. Duda, et al. Insights into Mesenchymal Stem Cell Aging: Involvement of Antioxidant Defense and Actin Cytoskeleton Stem Cells, June 1, 2009; 27(6): 1288 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tada and T. Kashimura Proteomic Analysis of Salt-Responsive Proteins in the Mangrove Plant, Bruguiera gymnorhiza Plant Cell Physiol., March 1, 2009; 50(3): 439 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. McDonald, J. Y. Yang, V. Marathe, T.-Y. Yen, and B. A. Macher Combining Results from Lectin Affinity Chromatography and Glycocapture Approaches Substantially Improves the Coverage of the Glycoproteome Mol. Cell. Proteomics, February 1, 2009; 8(2): 287 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Baharvand, A. Fathi, D. van Hoof, and G. H. Salekdeh Concise Review: Trends in Stem Cell Proteomics Stem Cells, August 1, 2007; 25(8): 1888 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fraterman, U. Zeiger, T. S. Khurana, M. Wilm, and N. A. Rubinstein Quantitative Proteomics Profiling of Sarcomere Associated Proteins in Limb and Extraocular Muscle Allotypes Mol. Cell. Proteomics, April 1, 2007; 6(4): 728 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. W. T. Chan, C. G. Howes, and L. J. Foster Quantitative Comparison of Caste Differences in Honeybee Hemolymph Mol. Cell. Proteomics, December 1, 2006; 5(12): 2252 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Lee and J. H. P. Hui The potential of stem cells in orthopaedic surgery J Bone Joint Surg Br, July 1, 2006; 88-B(7): 841 - 851. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |